We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

6 hedge funds and large institutions have $28K invested in PDL BioPharma, Inc. in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

79% less capital invested

Capital invested by funds: $130K → $28K (-$102K)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q1 2024 in Review

6 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q1 2024, worth a combined $28K — down 79% from $130K a quarter earlier.

Fund positioning in PDLI was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $28K of PDL BioPharma, Inc. stock for Q1 2024, down 79% quarter-over-quarter.
  • 0 funds opened new PDL BioPharma, Inc. positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.